Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized comparison of follitropin delta versus Gonal-f starting doses for controlled ovarian stimulation in Chinese women undergoing ART
CTR20233819Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of follitropin delta, follitropin alfa in female infertility, sponsored by Ferring Pharmaceuticals. Started Dec 2023; status: completed.
02
Drugs
follitropin deltafollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20233819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233819.